Avantel Reports Q1 Results; Board Approves Key Personnel Changes Including Director Appointments
Avantel Limited announced its un-audited Standalone and Consolidated Financial Results for the first quarter (Q1) ended June 30, 2026. The results were approved by the Board of Directors. Additionally, the Board meeting on July 11, 2026, addressed significant governance matters, including revisions to senior executive remuneration and the appointment of new directors.Financial Performance Review (Q1 Ended June 30, 2026)
The company reported its Q1 results in both standalone and consolidated formats.Standalone Un-audited Financial Results (Quarter ended 30/06/2026)
| Particulars | Quarter Ended 30/06/2026 (Un Audited) | Quarter Ended 31/03/2026 (Audited) | 30/06/2025 (Un Audited) | Year ended March 31, 2026 (Audited) |
|---|---|---|---|---|
| Revenue from operations | 7012.34 | 6314.66 | 5183.65 | 22135.23 |
| Total Income | 7023.89 | 6423.54 | 5188.17 | 22380.90 |
| Cost of materials consumed | 2501.97 | 2556.87 | 830.34 | 7678.49 |
| Total Expenses | 5931.69 | 5461.29 | 4518.24 | 19163.69 |
| Profit before tax | 1092.20 | 962.25 | 669.93 | 3217.21 |
| Net Profit for the Period | 761.77 | 705.23 | 462.40 | 2249.97 |
Consolidated Un-audited Financial Results (Quarter ended 30/06/2026)
| Particulars | Quarter Ended 30/06/2026 (Un Audited) | Quarter Ended 31/03/2026 (Audited) | 30/06/2025 (Un Audited) | Year ended March 31, 2026 (Audited) |
|---|---|---|---|---|
| Revenue from operations | 7042.16 | 6382.55 | 5191.28 | 22287.24 |
| Total Income | 7054.24 | 6492.99 | 5195.80 | 22534.47 |
| Cost of materials consumed | 2544.90 | 2650.52 | 828.46 | 7873.32 |
| Total Expenses | 6184.35 | 5761.34 | 4665.56 | 20070.69 |
| Profit before tax | 869.89 | 731.65 | 530.24 | 2463.78 |
| Net Profit for the Period | 539.46 | 477.47 | 322.71 | 1499.38 |
Segment-Wise Performance Analysis
The company operates in two main segments: Communications and signal processing products, and Health Care Services. The segment performance data for Q1 ended June 30, 2026, is summarized below:| Particulars | Communications and signal processing products | Health Care |
|---|---|---|
| Gross Revenue from sale of Products and services (in Lakhs) | 7,023.88 | 30.36 |
| Profit before tax (in Lakhs) | 1,092.19 | (222.30) |
| Total Assets (in Lakhs) | 47,161.70 | 2,591.47 |
Governance and Executive Changes
The Board meeting approved several key governance decisions regarding executive leadership:- Remuneration Revision: The remuneration of Mr. Abburi Siddhartha Sagar, Executive Director (Strategy & Business Development), was revised from Rs. 48.00 Lakhs per annum to Rs. 55 Lakhs per annum, effective July 11, 2026.
- Re-appointment of Executive Director: The Board considered the re-appointment of Mr. Abburi Siddhartha Sagar as Executive Director (Strategy & Business Development) for five consecutive years, commencing from March 8, 2027, up to March 7, 2032, subject to shareholder approval through Postal Ballot.
- New Directorship: Mr. Peddi Bala Bhaskar Rao was approved for appointment as an Additional Director, designated as Director (Operations), for a term of three consecutive years, effective from July 11, 2026, up to July 10, 2029. This appointment is subject to shareholder approval via Postal Ballot.
- Independent Directorship: Mr. Vyasabhattu Ramchander was approved for re-appointment as an Independent Director of the Company for a second consecutive term of five years, starting May 6, 2027, and ending on May 5, 2032, subject to approval by Members through Postal Ballot.
- Committee Restructuring: The Board also approved the reconstitution of the Audit Committee, Nomination and Remuneration Committee, and Stakeholders' Relationship Committee with immediate effect.
AVANTEL Stock Price Movement
On Friday, shares of Avantel Limited edged higher to close at ₹180.19, marking a 0.49% gain as the stock traded in the Capital Goods sector. The equity saw trading volume reaching 2.91 million, moving within an intraday range bounded by a low of ₹177 and a high of ₹183.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.